Geoff Bell:
Chief Executive Officer and Chairman.
Geoff holds a Bachelor of Science degree from the University of Sydney, plus a
Bachelor of Economics degree and Master of Applied Finance degree from Macquarie
University. He has been an associate director of AME Mineral Economics, a senior
analyst at Prudential-Bache Securities, and a senior analyst and Head of Global
Mining and Australian Research at BNP Paribas Equities. He was also Head of
Company Research for the Asia Pacifc Region for BNP Paribas Equities. Through
his career as an analyst he was top rated in his field for several years and won
a number of industry awards including Best Idea of the Year at the annual
stockbroker awards received the Best Gold Research award from the Australian
Gold Council. He has extensive experience in developing unique research models,
team building, financial analysis and advice. Geoff provides a strong financial
focus and guidance to MBG.
Dr. Paul Attfield:
Executive Director and Director of Operations.
Paul provides IP and know-how, the fermentation industry contacts and technical
management skills. He has over 30 years experience of technical and management
experience in global food, fermentation and pharmaceutical companies - 20
working on industrial yeasts. He has also worked extensively in academia and
non-commercial research organizations. Paul has served as a member of the
management committee for the Cooperative Research Centre for Food Industry
Innovation. He is highly experienced in technical team building and the
development and management of collaborative projects. Paul is an internationally
recognized yeast technologist with strong contacts in the global microbial
biotech industry. He has a Bachelor of Science (Honors First Class) degree in
applied biology and a Ph.D. in microbial genetics and physiology from the
University of London, UK. Paul has over 80 publications including book chapters,
refereed journal articles and contributions to international and national
scientific and technical meetings.
Dr. Phil Bell:
Director and Head of R&D.
He provides IP and the drive for technical innovation. Phil has over 15 years
experience in the biotechnology industry, with over 10 years experience in the
development of novel technology in the fields of yeast genetics and
biochemistry, as well as non-GMO strain development technology. Phil holds a
Bachelor of Sciences (Honors) degree from Sydney University and a Ph.D in yeast
biochemistry and molecular genetics from the University of New South Wales. He
has over 30 publications including book chapters, refereed journal articles and
contributions to international and national scientific and technical meetings.
Phil is the inventor/ discoverer of a unique fungal-produced fluorescent
compound that has broad applications in proteomics, genomics, cell labeling and
immunology.
Our novel purely non-GM approach is based on our
observation that natural strains of S. Cerevisiae can in fact produce
microscopic colonies using xylose as a sole carbon source, provided they can be
incubated for long enough periods (1-2 months).
This unexpected observation directly contradicts scientific dogma established
for many years, which states that 'Saccharomyces cerevisiae cannot grow at all
on xylose'. Using technology based on natural breeding and evolution we have
been able to generate Saccharomyces yeast strains with improved ability to grow
on xylose. Using our strategies, the rate of improvement in growth rate has been
exponential. Doubling times of yeast have been reduced from over 140 hours to
approximately three hours. Extrapolation of our data predicts that if growth
rates continue to improve according to the current trajectory, growth rates on
xylose equivalent to those observed on glucose will be achieved in approximately
18 months.
Significantly, ethanol production commenced from our strains when their growth
rates became faster than approximately 6 hours per generation on xylose mineral
minimal medium. The rate of improvement in ethanol production has been
exponential and increased over four fold in five months and is continuing to
improve in concert with growth rate. Our data suggests that we will achieve
industrially relevant rates of ethanol production as early as 18 months from
now. Biochemical investigations into differences between slow and fast growing
strains reveals faster strains have a hundred-fold increase in xylitol
dehydrogenase activities, a 10-fold increase in xylose reductase activity, and
slight increases in xylulose kinase activity. These differences indicate that
our strategy is individually optimising specific activities within the relevant
biochemical pathways.
Since our classically based technology does not involve any genetic engineering
steps to obtain improved yeasts of industrial quality, the yeast produced are
not subject to the same level of regulatory constraint as GM organisms. In
addition, by incorporating classical genetics technologies we have established
for generating improved yeast for the traditional fermentation industry, we are
aiming to produce yeast strains capable of slotting seamlessly into the
established infrastructure for ethanol manufacture. If these goals can be
achieved, the transition from a corn based ethanol industry to a corn stover
based industry can be accomplished with a minimum of new capital investment.
10 July 2006:
Australian Federal Government: Future Oil Supply Inquiry
Microbiogen submission to Senate Committee
Oil Supply Inquiry Link
12 October 2006:
The Energy Alternative: Reporter - Dr Paul Willis
Click this link to play the video
Segment from the ABC science series - Catalyst
12 October 2006:
The Energy Alternative: Reporter - Dr Paul Willis
Transcript from the ABC science series - Catalyst
Catalyst Transcript Link